Well... it's true though... Market analysts' sole job is to deduce risk/reward.
source: https://gradireland.com/careers-advice/job-descriptions/risk-analyst
I would argue the short term risk/reward has now changed since shortly after the Zapato-1 outcome. Now that investors are not faced with the high risk of Zapato's success, they can now look toward Alameda-1's appraisal, which has already found oil.
source: https://www.thebalancemoney.com/risk-to-reward-ratio-1031350
Source: Beginners guide to Security Analysis and Portfolio Management, May. 10, 2013 Deepika S.R. Assistant Professor.
Source: Beginners guide to Security Analysis and Portfolio Management, May. 10, 2013 Deepika S.R. Assistant Professor.
The risk of Zapato-1's money drain of about $100,000 per day ceased. All attention has now gone back to Alameda-1. Also, there seemed to be a sharp sentiment change after Zapato-1's total depth, (from bullish to bearish) telling me the "risk" leading to the Zapato asset outcome, possibly caused some shareholders to sell.
Now without the exploration "risk" of Zapato, we are moving to Alameda, which has a significantly higher chance of success in my opinion, not for exploration, but for commercial discovery. The same thing happens with almost any explorer on the ASX, they get hardly any share price momentum until they are about to start a drill for a potential discovery. Why? Because in the meantime instead of waiting you can be trading elsewhere (opportunity cost).
- Forums
- ASX - By Stock
- MAY
- May Chart
May Chart, page-4438
-
- There are more pages in this discussion • 8,448 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAY (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.003(13.6%) |
Mkt cap ! $84.25M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 2.2¢ | $309.3K | 13.30M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 4418678 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.024 |
9 | 706664 | 0.023 |
11 | 3965602 | 0.022 |
21 | 1930479 | 0.021 |
26 | 4259696 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 4418678 | 8 |
0.026 | 566965 | 6 |
0.027 | 557940 | 6 |
0.028 | 1519170 | 6 |
0.029 | 1908000 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MAY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online